Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed.
Authors
- Andrew R. Lloyd (ORCID: https://orcid.org/0000-0001-6277-8887)
- Adrian Dunlop (ORCID: https://orcid.org/0000-0003-2394-5966)
- Behzad Hajarizadeh (ORCID: https://orcid.org/0000-0003-2212-2028)
- Shane Tillakeratne (ORCID: https://orcid.org/0000-0002-5988-3579)
- Jeff Powis (ORCID: https://orcid.org/0000-0003-2053-6083)
- Evan B. Cunningham (ORCID: https://orcid.org/0000-0002-8048-3473)
- Janaki Amin (ORCID: https://orcid.org/0000-0003-2161-9366)
- Tanya Applegate (ORCID: https://orcid.org/0000-0002-8657-4261)
- Alexander M. Wong (ORCID: https://orcid.org/0000-0002-5295-2797)
- Lise Lafferty (ORCID: https://orcid.org/0000-0002-8533-2957)
- Kate Mason (ORCID: https://orcid.org/0000-0001-5020-5256)
- Martin Weltman (ORCID: https://orcid.org/0000-0002-1677-7653)
- Phillip Read (ORCID: https://orcid.org/0000-0001-5422-3777)
- Alexandra Wade
- Jason Grebely (ORCID: https://orcid.org/0000-0002-1833-2017)
- Joshua Ping Ang (ORCID: https://orcid.org/0000-0003-2521-3590)
- Carla Treloar (ORCID: https://orcid.org/0000-0002-8230-0386)
- Gregory J. Dore (ORCID: https://orcid.org/0000-0002-4741-2622)
- Gail Matthews (ORCID: https://orcid.org/0000-0002-1048-6396)
- Emily Rowe
- Dennaye Fuchs
- Edward Gane (ORCID: https://orcid.org/0000-0003-4086-7955)
- Marianne Martinello (ORCID: https://orcid.org/0000-0001-9444-0186)
- Chris Fraser
- David Baker
- Brian E. Conway
- Louisa Degenhardt
- Jodi Van Dyk
Institutions
- Royal Adelaide Hospital (AU)
- University of Auckland (NZ)
- University of Regina (CA)
- Saskatchewan Health (CA)
- Nepean Hospital (AU)
- Toronto East General Hospital (CA)
- Blacktown & Mount Druitt Hospital (AU)
- UNSW Sydney (AU)
- Vancouver Infectious Diseases Centre (CA)
- Regent Park Community Health Centre (CA)
- St Vincent's Clinic (AU)
- Central Coast Local Health District (AU)
- South Eastern Sydney Local Health District (AU)
- Hunter New England Local Health District (AU)
- Macquarie University (AU)
Publication Details
- Journal
- International Journal of Drug Policy
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1016/j.drugpo.2025.104859
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Department of Health and Ageing, Australian Government
- Government of Western Australia
- National Health and Medical Research Council